Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker - Test2 - elhamkhani - TriplyDB

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

http://www.wikidata.org/entity/Q24648238

about

The emerging roles of human tissue kallikreins in cancer In silico analysis of the human kallikrein gene 6.Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display.Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.Ovarian cancer biomarkers for molecular biosensors and translational medicine.OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.Human tissue kallikreins and testicular cancer.High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis.The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer The kallikrein world: an update on the human tissue kallikreins.Cellular distribution of human tissue kallikreins: immunohistochemical localization.Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry Characterization of Human Kallikreins 6 and 10 in Ascites Fluid from Ovarian Cancer Patients Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

P2860

Q28290701-FBD09C58-3D8C-4292-B0BF-10FC85961DA3 Q33210507-1A67A9B2-BDDC-43AD-A728-77CA16D3F412 Q33382170-C8BDC6DF-654D-43D1-AA03-A65D0941C1E0 Q33794911-D5D7080A-68F4-490A-8040-5B8938C0F258 Q34150097-EA13621D-D181-46D1-BB52-799AE77046B9 Q34582595-9038A5B5-AB39-4063-B425-E47E6F6F449E Q35032994-42A48114-99AE-4307-BB78-982C5DD4CDF2 Q35129502-A325193D-D21F-449C-900F-D6868BB35443 Q35893466-B74749C7-9A3D-472B-ACB9-B5713DFA4C90 Q35976828-3EBF3E64-6166-4ED0-A9E2-BA6EB66E794A Q36075255-211151D6-1C7E-4A2A-92EF-7FBD219050E3 Q36519354-140A08BE-DAEE-4193-BB7B-7087C2C573C4 Q36519359-C1B41092-CD60-44E3-8D5B-87AD5B1FB28F Q36609685-DB55DDDD-B1EB-4450-8EAE-83BBF69CB48D Q36936018-46ECAA4B-0E73-4580-8A7A-A4C35824B8AF Q37154456-A52F8E15-17F8-446C-A4CC-923C5928B425 Q37400530-013974D0-D3DC-49DB-9B43-0901DBB70F52 Q37690308-B6EF0BA3-9059-4C7E-97ED-44DE3FA2E4C5 Q37952006-6B2120E5-9CC9-4B10-95D8-23AF64E46BCD Q37960202-C732D39C-3695-4458-84EA-8FAC1238139A Q38184632-DDD94940-E31E-4165-882A-7DEA9F9F622E Q39080408-D1600210-500A-4D13-A0E9-417434EF4FB6 Q39388749-172B1E56-5F2B-4421-A548-811B29937332 Q40262739-E3E80490-76EF-4D48-8C99-6C6CF1E4B40B Q43418010-2C38BF10-C85A-450C-A44C-589150240B39 Q43489162-07A568E5-7B9E-4F73-BBDB-D7A077AEEBB9 Q56888917-3FEDE649-50AD-483B-889D-82C362EF77E8 Q57940871-1FA840B9-DD2A-48E5-9301-9EBD67764C1E Q57941738-078EFCB1-7419-43D7-B362-C6A6A27D6089 Q57942209-94708EA1-54F8-4D9B-962D-3F2328D6951E

P2860

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

http://www.wikidata.org/entity/Q24648238

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@ast

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@en

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@nl

type

label

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@ast

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@en

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@nl

prefLabel

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@ast

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@en

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@nl

P1433

Q24648238-3DD24E37-FF95-4F29-A034-63E6DD970D11

P1476

Q24648238-E194EA9C-D4B3-4A0F-BF14-61C63322DFCE

P2093

Q24648238-18CC1F75-7CDD-4AD7-8ED6-A2ABCBB8FC61

Q24648238-1C360976-FCE3-4431-B2AB-C08FE4601DD8

Q24648238-388C36FB-7548-4666-B0CA-3CE3D391549B

Q24648238-3EBD63FC-9201-4441-8538-58BA37FBD1F3

Q24648238-50275FDC-6655-47F8-B199-7F3243A5E14D

Q24648238-768AD3D4-AF2C-48DC-8DBD-75D907E8FD69

Q24648238-80E8A9EF-4BE0-4D39-AD29-49F1E83A36CB

Q24648238-B829A999-77F8-4897-8E3B-647C6FD4B1D4

Q24648238-F63DE1AA-72DC-449E-92C9-8C96FD80E243

P2860

Q24648238-0311956B-368D-4CCB-B52E-5FB1636A60ED

Q24648238-09BA3D3C-1402-4F49-966F-44105804A047

Q24648238-15C45ED3-1E2A-4D9B-A3C7-4BBA9D30CCB6

Q24648238-23340959-FBAB-4194-9105-24E5FF68FE7E

Q24648238-240B988F-F7EF-4611-871D-08AD46457ACD

Q24648238-2BE99A01-D3F9-48E0-9090-72372F7F6F40

Q24648238-2C55BCB0-9497-4937-8C24-E0CCD53A0AEA

Q24648238-2FE2F1B0-82DD-4558-9891-77C2A9E01595

Q24648238-3072C444-9CD4-49DC-88BE-835EA6893B7E

Q24648238-47407C20-B7CD-41B5-97AC-628A581D5CDA

P2888

Q24648238-AD62B1EE-E81D-4EFA-9E65-7BEF29365643

P304

Q24648238-F3E5C01C-2413-46E0-B326-DA8E36C755D5

P31

Q24648238-DFED34DB-23EA-4128-AAA3-45E41A94258B

P3181

Q24648238-9F55E005-5332-4F3E-B1CB-A3346EA9B72B

P356

Q24648238-8A68B106-B1C7-42A1-8BFA-79039F933C30

P407

Q24648238-BF8D6E76-A04C-4FE1-8A10-21729F4C57DB

P433

Q24648238-F80330EE-7F7E-4CFB-A9A6-97A75EA70D47

P478

Q24648238-A7796C4E-3B62-4CB8-BDF3-D0F6372783D6

P50

Q24648238-16450AC8-3A4F-4C96-A2D1-0C5C87185F61

Q24648238-59033A26-D09C-4993-B8FB-D6561126E684

P577

Q24648238-78ADBC22-32A0-43C7-82C9-B2B5D05D21CB

P5875

Q24648238-AAB025C9-B870-4883-914D-6422B1F99292

P6179

Q24648238-DFB3FE1F-1550-4B09-B867-9D9049DB51EB

P698

Q24648238-0A05A539-722B-410A-AD91-62CEA4BD62C0

P921

Q24648238-06D7F9F5-1212-4182-96AD-99F14F15FB05

Q24648238-4871378D-4C38-4906-83BA-DFD47F668DD6

P932

Q24648238-12C2E40A-FDAB-4968-A310-E5FBA45CC56E

P3181

P356

P1433

British Journal of Cancer

P1476

Immunofluorometric quantitatio ...... avourable prognostic biomarker

@en

P2093

B R Hoffman

http://www.w3.org/2001/XMLSchema#string

D Katsaros

http://www.w3.org/2001/XMLSchema#string

E P Diamandis

http://www.w3.org/2001/XMLSchema#string

G Giardina

http://www.w3.org/2001/XMLSchema#string

I A Rigault de la Longrais

http://www.w3.org/2001/XMLSchema#string

M Massobrio

http://www.w3.org/2001/XMLSchema#string

M Puopolo

http://www.w3.org/2001/XMLSchema#string

S Fracchioli

http://www.w3.org/2001/XMLSchema#string

T Colgan

http://www.w3.org/2001/XMLSchema#string

P2860

The new human kallikrein gene family: implications in carcinogenesis

Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues

Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

A novel protease homolog differentially expressed in breast and ovarian cancer

Nonparametric Estimation from Incomplete Observations

Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease

Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain

The role for NES1 serine protease as a novel tumor suppressor

Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain

P2888

P304

763-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4973377

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJC.6600533

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Phedias Diamandis

Andreas Scorilas

P577

2002-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11157267

http://www.w3.org/2001/XMLSchema#string

P6179

1012197737

http://www.w3.org/2001/XMLSchema#string

P698

12232761

http://www.w3.org/2001/XMLSchema#string

P921

P932

2364256

http://www.w3.org/2001/XMLSchema#string